These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645 [TBL] [Abstract][Full Text] [Related]
4. Algorithm for Pompe disease newborn screening: results from the Taiwan screening program. Chiang SC; Hwu WL; Lee NC; Hsu LW; Chien YH Mol Genet Metab; 2012 Jul; 106(3):281-6. PubMed ID: 22578805 [TBL] [Abstract][Full Text] [Related]
5. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Zhang H; Kallwass H; Young SP; Carr C; Dai J; Kishnani PS; Millington DS; Keutzer J; Chen YT; Bali D Genet Med; 2006 May; 8(5):302-6. PubMed ID: 16702880 [TBL] [Abstract][Full Text] [Related]
6. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots. Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480 [TBL] [Abstract][Full Text] [Related]
7. Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program. Labrousse P; Chien YH; Pomponio RJ; Keutzer J; Lee NC; Akmaev VR; Scholl T; Hwu WL Mol Genet Metab; 2010 Apr; 99(4):379-83. PubMed ID: 20080426 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening for Pompe disease in Japan. Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784 [TBL] [Abstract][Full Text] [Related]
9. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449 [TBL] [Abstract][Full Text] [Related]
10. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease. Lin N; Huang J; Violante S; Orsini JJ; Caggana M; Hughes EE; Stevens C; DiAntonio L; Chieh Liao H; Hong X; Ghomashchi F; Babu Kumar A; Zhou H; Kornreich R; Wasserstein M; Gelb MH; Yu C Clin Chem; 2017 Apr; 63(4):842-851. PubMed ID: 28196920 [TBL] [Abstract][Full Text] [Related]
11. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease. Wang Z; Okamoto P; Keutzer J Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919 [TBL] [Abstract][Full Text] [Related]
12. Pompe disease ascertained through The Lantern Project, 2018-2021: Next-generation sequencing and enzymatic testing to overcome obstacles to diagnosis. Sniderman King L; Pan Y; Nallamilli BRR; Hegde M; Jagannathan L; Ramachander V; Lucas A; Markind J; Colzani R Mol Genet Metab; 2023 May; 139(1):107565. PubMed ID: 37087815 [TBL] [Abstract][Full Text] [Related]
13. Newborn screening for Pompe disease in Japan: report and literature review of mutations in the GAA gene in Japanese and Asian patients. Momosaki K; Kido J; Yoshida S; Sugawara K; Miyamoto T; Inoue T; Okumiya T; Matsumoto S; Endo F; Hirose S; Nakamura K J Hum Genet; 2019 Aug; 64(8):741-755. PubMed ID: 31076647 [TBL] [Abstract][Full Text] [Related]
14. Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease. Liao HC; Chan MJ; Yang CF; Chiang CC; Niu DM; Huang CK; Gelb MH Clin Chem; 2017 Jul; 63(7):1271-1277. PubMed ID: 28450385 [TBL] [Abstract][Full Text] [Related]
15. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy. Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735 [TBL] [Abstract][Full Text] [Related]
17. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry. Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766 [TBL] [Abstract][Full Text] [Related]
18. Is early detection of late-onset Pompe disease a pneumologist's affair? A lesson from an Italian screening study. Confalonieri M; Vitacca M; Scala R; Polverino M; Sabato E; Crescimanno G; Ceriana P; Antonaglia C; Siciliano G; Ring N; Zacchigna S; Salton F; Vianello A; Orphanet J Rare Dis; 2019 Mar; 14(1):62. PubMed ID: 30832705 [TBL] [Abstract][Full Text] [Related]
19. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment. Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590 [TBL] [Abstract][Full Text] [Related]
20. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Umapathysivam K; Hopwood JJ; Meikle PJ Clin Chem; 2001 Aug; 47(8):1378-83. PubMed ID: 11468225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]